Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
Unmodified antibodies (abs) have been successful in the treatment of hematologic malignancies, but less so for the treatment of solid tumors. They trigger anti-tumor effects through their Fc-domains, and one way to improve their efficacy is to optimize their interaction with the effectors through Fc...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2012-06-01
|
| coleção: | Antibodies |
| Assuntos: | |
| Acesso em linha: | http://www.mdpi.com/2073-4468/1/1/88 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|